Phase I/II study of S-1, cisplatin and docetaxel in patients with advanced gastric cancer

Trial Profile

Phase I/II study of S-1, cisplatin and docetaxel in patients with advanced gastric cancer

Completed
Phase of Trial: Phase I/II

Latest Information Update: 30 Jun 2016

At a glance

  • Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Gastric cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 11 Sep 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 12 Apr 2011 Planned end date changed from 1 Apr 2009 to 1 Aug 2011 as reported by University Hospital Medical Information Network - Japan.
    • 12 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top